Trade Bristol Myers ^BMY

Is Hengrui's US$15.2 Billion Alliance Reshaping the Investment Case for Bristol Myers Squibb (BMY)?

DNB Asset Management AS Increases Position in Bristol Myers Squibb Company $BMY - Zolmax

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Bristol Myers Squibb turns to China's Hengrui to replenish pipeline

Q2 EPS Forecast for Bristol Myers Squibb Lowered by Analyst - Stock Observer

AustralianSuper Pty Ltd Decreases Stock Holdings in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Allworth Financial LP

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons

Bristol-Myers Squibb Co at Bank of America Global Healthcare Conference Transcript

Bristol-Myers Squibb (BMY): Buy, Sell, or Hold Post Q1 Earnings?

Bristol Myers Squibb Company $BMY Shares Sold by Trek Financial LLC - Daily Political

Berkeley Capital Partners LLC Trims Stock Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial

Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction

Bristol-Myers Shuts Down Lawsuit Over Celgene Investor Rights

10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar

China's Hengrui Partners with Bristol Myers Squibb in $15.2 Billion Licensing Deal, ETPharma

Dow Jones Top Company Headlines at 9 PM ET: Walmart Lays Off or Relocates About 1,000 Corporate Workers | SpaceX ... | Morningstar

Dow Jones Top Company Headlines at 7 PM ET: Walmart Lays Off or Relocates About 1,000 Corporate Workers | EBay ... | Morningstar

Bristol Myers Squibb signs $15.2 billion drug deal with China's Hengrui as patent cliff looms

Bristol Myers Squibb (BMY) Partners with Hengrui Pharma for $15.2B R&D Collaboration

Bristol Myers, Hengrui Pharma Partners On 13 Drug Programs In $15.2B Deal

Is BMY Undervalued? DCF Says Worth $74

Dow Jones Top Company Headlines at 7 AM ET: EBay Rejects GameStop's $56 Billion Takeover Proposal | JD.com ... | Morningstar

North American Morning Briefing: Futures Decline as Iran Peace Progress Weighs | Morningstar

China's Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS

Dow Jones Top Company Headlines at 5 AM ET: Bristol-Myers Squibb and China's Hengrui Pharma Forge Tie-Up | Sam ... | Morningstar

China's Jiangsu Hengrui, Bristol Myers Squibb sign deals worth up to $15.2b

Dow Jones Top Company Headlines at 3 AM ET: Bristol-Myers Squibb and China's Hengrui Pharma Forge Tie-Up | Sam ... | Morningstar

Hengrui Medicine Partners with BMS for $15.2 Billion Global Collaboration

China's Hengrui, Bristol Myers Squibb sign collaboration, licensing deals - AOL

Advancing the 'best of both' - BMS, Hengrui enter $15.2B deal | BioWorld

Bristol-Myers Squibb Company (BMY) Myers Beats Quarterly Profit Estimates

Hengrui Pharma and Bristol Myers Squibb to advance innovative medicines across oncology, hematology, immunology

Drug companies involved in TrumpRx boosted lobbying by 23% ahead of program's launch

Tildrakizumab Market Research Report 2026: $3+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

American factories lag in adopting AI. This drugmaker is an exception

Bristol Myers Squibb Company $BMY Stock Position Decreased by Securian Asset Management Inc. - Zolmax

SVB Wealth LLC Sells 9,404 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Shares Acquired by Swiss Life Asset Management Ltd - Stock Observer

5 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen

Bristol Myers Squibb Company $BMY Position Boosted by Oxbow Advisors LLC

Bristol Myers Squibb Touts Pipeline Gains as Shareholders Back Board at Annual Meeting

Hikari Power Ltd Sells 12,000 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Sotyktu Psoriatic Arthritis Nod Broadens Bristol Myers Squibb Immunology Story

The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial

Manning & Napier Advisors LLC Decreases Position in Bristol Myers Squibb Company $BMY

LJI Wealth Management LLC Takes $2.11 Million Position in Bristol Myers Squibb Company $BMY

Drucker Wealth 3.0 LLC Makes New $1.12 Million Investment in Bristol Myers Squibb Company $BMY - Daily Political

Bristol Myers Squibb accused of buying off competitors to delay development of generic cancer drugs

Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Pharma Sector Sentiment Shift Accurately

GRIMES & Co WEALTH MANAGEMENT LLC Sells 28,024 Shares of Bristol Myers Squibb Company $BMY - Zolmax

GRIMES & Co WEALTH MANAGEMENT LLC Reduces Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Bought by Generali Asset Management SPA SGR

Bristol Myers Squibb Company $BMY Stock Position Raised by RFG Advisory LLC - Stock Observer

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial

The Agencies Building Pharma's Next Decade Just Picked Their Software: Daily Command Launches With 18 of the Industry's Most Senior Agency Leaders Already Inside It

Premier Fund Managers Ltd Invests $11.63 Million in Bristol Myers Squibb Company $BMY

IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading

Principal Financial Group Inc. Reduces Stake in Bristol Myers Squibb Company $BMY

6 Pharma Dividend Stocks Yielding Up to 6.44% - and They've Survived Every Market Crash

Bokf Na Reduces Stock Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by RNC Capital Management LLC

Truist Financial Corp Trims Stake in Bristol Myers Squibb Company $BMY

Pinnacle Wealth Management Advisory Group LLC Increases Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Shares Bought by Intact Investment Management Inc. - Stock Observer

Christine Messmer PC Makes New Investment in Bristol Myers Squibb Company $BMY - Stock Observer

In FIFA-Tied Corporate Campaign, Bristol Myers Squibb 'Won't Lose' 05/05/2026

Seizert Capital Partners LLC Acquires 38,725 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Launches "Won't Lose" Media Campaign Ahead of FIFA World Cup 2026™

M&T Bank Corp Purchases 13,307 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Bristol Myers beats quarterly profit estimates on blood thinner, cancer drug sales

A Look At Bristol Myers Squibb (BMY) Valuation After Its Q1 2026 Earnings Beat And Reaffirmed Guidance

BMY: Upcoming Late Stage Readouts Will Drive Potential Re Rating Opportunity

Scotiabank Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY) | Markets Insider

Bristol Myers Squibb Company $BMY Shares Bought by CX Institutional

Bristol Myers Squibb Company (NYSE:BMY) Given Average Recommendation of "Hold" by Brokerages - Zolmax

Strs Ohio Sells 46,600 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Robertson Stephens Wealth Management LLC Increases Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Q1 Earnings Call Highlights - Zolmax

Bristol Myers Squibb (BMY) Margin Strength In Q1 2026 Challenges Bearish Earnings Narratives

Bristol Myers Squibb Company $BMY Shares Sold by Danske Bank A S

GC Wealth Management RIA LLC Reduces Stake in Bristol Myers Squibb Company $BMY

PFA Pension Forsikringsaktieselskab Makes New Investment in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 - Data Talk | Morningstar

Big Pharma M&A set for mega year as patent expiries drive deal urgency

Bristol-Myers Squibb Company (NYSE:BMY) Q1 2026 Earnings Call Transcript

Bristol Myers Squibb Company $BMY Shares Sold by New York State Teachers Retirement System

Is Bristol Myers Squibb (BMY) Still Attractively Priced After Its Strong 1 Year Share Price Gain

Bristol Myers Squibb Q1 Earnings Call Highlights

US Bancorp DE Sells 119,454 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol-Myers Squibb Co (BMY) Q1 2026 Earnings Call Highlights: Navigating Growth and ...

BMY SWOT Analysis: Financial Resilience Amidst Market Challenges Revealed in 10-Q Filing